Riskpilot← Back to searchSign inGet full accessCartilago AB
ABActiveOrg 5569980294Klostergatan 24Medical specialists activities · NACE 8622Est. 20142 employees
Revenue 2025
SEK 3M
-8% vs 2024
EBITDA margin
31.0%
+7% vs 2024
Equity ratio
58.6%
Financial strength
Net profit 2025
SEK 936K
+26% vs 2024
| Revenue | SEK 3M | -8% |
| EBITDA | SEK 936K | +7% |
| Net profit | SEK 936K | +26% |
| Total assets | SEK 3,7M | -6% |
| Equity | SEK 2,2M | +2% |
| Employees | 2 | — |
Legal name
Cartilago AB
Org number
5569980294
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
22 december 2014
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukvård, medicinsk konsultverksamhet, utbildning, forskning, utveckling, utgivning av litteratur, konstnärlig verksamhet, äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Klostergatan 24
Email
cartilago.se@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 308 | 3 477 | 3 273 | 3 270 | 3 021 |
| Staff expenses | — | — | — | — | −454 |
| EBITDA | 1 317 | 1 036 | 1 078 | 878 | 936 |
| Depreciation & amort. | −27 | −27 | −27 | −11 | — |
| EBIT | 1 290 | 1 009 | 1 051 | 867 | 936 |
| Net financials | 15 | 36 | 25 | 128 | 22 |
| Profit before tax | 1 121 | 911 | 910 | 938 | 1 193 |
| Tax | −244 | −191 | −192 | −193 | −257 |
| Net profit | 877 | 720 | 718 | 745 | 936 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 351 | 3 760 | 4 128 | 3 909 | 3 688 |
| Equity | 1 594 | 1 939 | 2 282 | 2 127 | 2 163 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 432 | 362 | 222 | 101 | 80 |
| Total debt | 432 | 362 | 222 | 101 | 80 |
EBITDA margin
31.0%
This company
15.8%
Market median
+96% vs market
20212025
Equity ratio
58.6%
This company
38.2%
Market median
+53% vs market
20212025
Return on equity
43.3%
This company
18.4%
Market median
+135% vs market
20212025
Net profit margin
31.0%
This company
8.1%
Market median
+283% vs market
20212025
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20212025
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CG | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cartilago AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl-Johan Georg Sandberg | Audit | 0 companies |
| Johan Erik Axel Thorén | Deputy Board Member | 0 companies |
| Johan Magnus Gunnar Lundberg | Board of Directors | 0 companies |